Myeloid-derived growth factor suppresses VSMC dedifferentiation and attenuates postinjury neointimal formation in rats by activating S1PR2 and its downstream signaling.
Yang S, Li HW, Tian JY, Wang ZK, Chen Y, Zhan TT, Ma CY, Feng M, Cao SF, Zhao Y, Li X, Ren J, Liu Q, Jin LY, Wang ZQ, Jiang WY, Zhao YX, Zhang Y, Liu X.
Yang S, et al. Among authors: liu x, liu q.
Acta Pharmacol Sin. 2024 Jan;45(1):98-111. doi: 10.1038/s41401-023-01155-x. Epub 2023 Sep 19.
Acta Pharmacol Sin. 2024.
PMID: 37726422